FINANCIAL COMMUNICATIONS

SPJ provides financial communications support for listed and non-listed companies. This essentially entails assisting these organisations to tell ‛the story behind the numbers’.
Financial Communications >

CORPORATE COMMUNICATION

The support SPJ provides in the field of corporate communications enables organisations to gain control over their image. Our aim is to achieve sustainable results.
Corporate Communication >

CORPORATE EDITING

SPJ specialises in formulating clear written messages aligned to the different target groups. These target groups can range from shareholders, consumers and government policymakers.
Corporate Editing >

INTERIM MANAGEMENT

SPJ temporarily fulfils the position of overall responsibility in the field of corporate communications. The nature of the projects in essence always amounts to delivering brainpower.
Interim Management >

About SPJ

Profile


SPJ is an independent financial and corporate communications agency. While the partners of SPJ have diverse professional backgrounds, they all share one vision of communications. The partner structure safeguards our independence vis-à-vis the approach to our profession and ensures stability regarding the composition of the team. This combines to establish a firm foundation for developing long-term relationships with clients.

SPJ focuses on optimally achieving the results envisioned by clients. We also, however, always maintain an independent vision of what we consider to be feasible and/or desirable in the client’s best interest.

 

Vision

We are substantively interested in our clients’ business operations and challenges. We care about their organisations’ performance and are dedicated to providing them with top-level support in communications. Even though the related focus is on advice, we fully realise that a flawless execution is inextricably linked to this. We are also aware that there is rarely a sharp boundary between advice and execution and we never draw that line.

At SPJ we are able to reveal the core of organisations rapidly and to introduce transparency to their thoughts and actions. We see this as the starting point for various forms of communications aimed at developing long-lasting relationships with relevant stakeholders. This is achieved by translating the organisation’s story for each target group and by conveying it using the optimum mix of means and media.

 

International network

We share our expertise and ambitions with our partners within AMO, an international network of agencies that hold leading positions in their home markets. Like SPJ, the partner agencies within AMO also provide high-quality advice in the field of financial and corporate communications with a primary focus on M&A and capital market transactions, media relations, investor relations and corporate crises. This has led to a proven track record of mutual co-operation in the area of cross-border projects.

The AMO network comprises:

The Abernathy MacGregor Group in the US

Maitland in the UK

Euro RSCG C&O in France, Belgium and Dubai

Hering Schuppener in Germany

Llorente & Cuenca in Spain and Latin America

Hirzel.Neef.Schmid.Counselors in Switzerland

SPJ in the Netherlands

Porda Havas in China

Ad Hoc Communication Advisors in Italy

Springtime in Sweden

Léon Melens

 

After earning his law degree in Rotterdam, Léon fulfilled various communications positions at a range of listed companies and served as an independent advisor. He gained his passion for multimedia and television while working for the financial current events television programme Business Update. He joined SPJ as a partner in 1999.

Léon specialises in providing strategic advice and practical support for companies in the life science and medical sector and financial firms and institutions. Through the years he has developed extensive expertise in advising leading companies such as Fornix BioSciences, Prosensa, Cryo-Save, AMT and Genmab. He was also closely involved in producing the Rabobank Group annual report for a number of years.

Léon’s clients include Aperam, Cryo-Save, Galapagos and Genmab.

Linkedin